Open AccessCOVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
Author(s) -
Yi-Feng Wu,
Wanjun Yu,
Yuhua Jiang,
Cong Yin,
Bo Zhang,
Rui-Bing Zhen,
Juntao Zhang,
Yiping Wang,
Qiang Li,
Feng Xu,
Yifeng Shi,
Xian-Peng Li
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i19.5266
Subject(s) - medicine , immunosuppression , covid-19 , virology , hepatitis b virus , virus , immunology , infectious disease (medical specialty) , disease , outbreak
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported.